Dr. Datar is Dean, Harvard Business School and George F. Baker Professor of Business Administration. He was the Arthur Lowes Dickinson Professor at the Graduate School of Business Administration of Harvard University from 1996 to 2020 and is the former Faculty Chair of the Harvard Innovation Labs and Senior Associate Dean for University Affairs. From 1989 to 1996, he was Edmund W. Littlefield Professor at the Graduate School of Business, Stanford University. Dr. Datar is also a director of Novartis AG, a multinational pharmaceutical and consumer health products company, ICF International, Inc., a management, technology and policy consulting firm, and T-Mobile US, Inc., a provider of wireless voice, messaging and data services.
Dr. Datar has an extensive background in accounting and finance and a variety of other business areas, including performance measurement, design thinking and innovation, and machine learning and artificial intelligence. His strong academic and business background and his experience on the board committees of other companies allow him to make significant contributions to our board. His service on the boards of global companies involved in pharmaceuticals and high tech gives him great insights on assessing our technology and strategies to expand our business globally.
In 2020, Dr. Datar was recognized by the National Association of Corporate Directors (NACD) as the Public Company Director of the Year.
What is Srikant M. Datar's net worth?
The estimated net worth of Srikant M. Datar is at least $1.98 million as of December 5th, 2022. Dr. Datar owns 7,262 shares of Stryker stock worth more than $1,981,800 as of February 6th. This net worth evaluation does not reflect any other investments that Dr. Datar may own. Learn More about Srikant M. Datar's net worth.
How do I contact Srikant M. Datar?
Has Srikant M. Datar been buying or selling shares of Stryker?
Srikant M. Datar has not been actively trading shares of Stryker over the course of the past ninety days. Most recently, Srikant M. Datar sold 1,000 shares of the business's stock in a transaction on Wednesday, December 7th. The shares were sold at an average price of $240.25, for a transaction totalling $240,250.00. Following the completion of the sale, the director now directly owns 6,262 shares of the company's stock, valued at $1,504,445.50. Learn More on Srikant M. Datar's trading history.
Who are Stryker's active insiders?
Stryker's insider roster includes Yin Becker (VP), William Berry, Jr. (VP), Glenn Boehnlein (CFO), Srikant Datar (Director), Roch Doliveux (Director), M. Fink (VP), Robert Fletcher (VP), Allan Golston (Director), Kevin Lobo (CEO), Katherine Owen (VP), Bijoy Sagar (VP), Timothy Scannell (COO), and Ronda Stryker (Director). Learn More on Stryker's active insiders.
Are insiders buying or selling shares of Stryker?
In the last year, insiders at the medical technology company sold shares 8 times. They sold a total of 80,079 shares worth more than $19,354,831.95. The most recent insider tranaction occured on January, 11th when VP M Kathryn Fink sold 6,571 shares worth more than $1,693,280.99. Insiders at Stryker own 6.5% of the company.
Learn More about insider trades at Stryker. Information on this page was last updated on 1/11/2023.
